Applied Clinical Trials October 2022 Issue (PDF)
Articles in this issue
Managing Biospecimens in Cell and Gene Therapy Trials
A Biosafety Perspective on Operational Challenges in Cell and Gene Therapy Studies
Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials
Rare Disease Clinical Trials: Strategies Learned from Duchenne Muscular Dystrophy
The Risk-Reward Proposition for CGT Clinical Trials
Philadelphia Shines in Cell and Gene Therapy Research Pursuits
Survey Investigates Backup Solution Adoption for ePRO Systems
A Pervasive Patient Focus in EU Clinical Trials as New Rules Face Fine-Tuning
Scientists Don’t Ever Stop Sciencing
Applied Clinical Trials October 2022 Issue (PDF)
Key Clinical Trial Industry Themes Post-COVID
Clinical Trial Modernization Raises FDA Compliance Issues
What the Future State Really Looks Like for Clinical Data Leaders
Related Content
Driving Diversity with the Integrated Research Model
October 16th 2024Podcast
Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Podcast
Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
